PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Our results demonstrate that PNPLA3-Ile148Met, PNPLA3-Lys434Glu, and TM6SF2-Glu167Lys significantly increase MASLD risk in Chinese children, thereby filling a critical research gap in this population.